Galena Biopharma (GALE) Will Make Two E75-Related Presentations at Upcoming CTRC-AACR Symposium

Galena Biopharma (Nasdaq: GALE) today announced two presentations at the 34th Annual CTRC-AACR San Antonio Breast Cancer Symposium. The event will be held December 6-10, 2011 at the Henry B. Gonzalez Convention Center in San Antonio, Texas.

Poster # P1-13-02 entitled, "Long-term clinical benefit of adjuvant breast cancer vaccine: 5 year efficacy of E75 with multiple booster inoculations," will be presented on Wednesday, December 7, 2011 from 5:00 pm to 7:00 pm CST during Poster Session 1.

Poster # OT3-01-18 entitled, "Combination immunotherapy with trastuzumab and the HER2 vaccine E75 in low and intermediate HER2-expressing breast cancer patients to prevent recurrence," will be presented on Friday, December 9, 2011 from 5:00 pm to 7:00 pm CST during the Ongoing Trials 3 Poster Session.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Ball Corporation (BALL) Raises Dividend, Enters 40M Share Buyback, Announces Management Changes
• F&M Bank (FMAO) Appoints Mark Hutchinson as Treasurer
• ADT Corp. (ADT) Appoints Jeffrey A. Likosar as Permanent CFO